Sean Wieland
Stock Analyst at Piper Sandler
(1.75)
# 3,333
Out of 5,005 analysts
31
Total ratings
40.91%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $30.95 | +77.71% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $24.09 | +49.44% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $6.33 | +1,795.73% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $52.54 | -88.58% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $73.26 | -39.94% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $206.63 | +11.79% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $9.01 | +3,129.74% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $30.95
Upside: +77.71%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $24.09
Upside: +49.44%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $6.33
Upside: +1,795.73%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $52.54
Upside: -88.58%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $73.26
Upside: -39.94%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $206.63
Upside: +11.79%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $9.01
Upside: +3,129.74%